NASDAQ:AYTU - Aytu BioScience Stock Price, Price Target & More

$0.56 -0.02 (-3.45 %)
(As of 04/25/2018 04:00 PM ET)
Previous Close$0.56
Today's Range$0.5450 - $0.5878
52-Week Range$0.38 - $15.80
Volume2.30 million shs
Average Volume2.08 million shs
Market Capitalization$3.19 million
P/E RatioN/A
Dividend YieldN/A
Beta6.63

About Aytu BioScience (NASDAQ:AYTU)

Aytu BioScience, Inc., a specialty healthcare company, focuses on developing and commercializing novel products in the field of urology in the United States. The company markets Natesto for the treatment of hypogonadism (low testosterone) in men; and ProstaScint for use in newly diagnosed high-risk prostate cancer patients and patients with recurrent prostate cancer. It is also involved in commercializing of the RedoxSYS System for research use in various applications. In addition, the company is developing MiOXSYS, an in vitro diagnostic semen analysis test that is used in the quantitative measurement of static oxidation reduction potential in human semen. Further, the company provides Fiera personal care device, a hands-free wearable product for women that is designed to enhance interest in and physical readiness for sex. Aytu BioScience, Inc. is based in Englewood, Colorado.

Receive AYTU News and Ratings via Email

Sign-up to receive the latest news and ratings for AYTU and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AYTU
CUSIPN/A
Phone720-437-6580

Debt

Debt-to-Equity RatioN/A
Current Ratio1.61%
Quick Ratio1.33%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$3.22 million
Price / Sales0.97
Cash FlowN/A
Price / CashN/A
Book Value$4.84 per share
Price / Book0.12

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-22,500,000.00
Net Margins-419.34%
Return on Equity-295.55%
Return on Assets-91.13%

Miscellaneous

Employees63
Outstanding Shares5,600,000

How to Become a New Pot Stock Millionaire

Aytu BioScience (NASDAQ:AYTU) Frequently Asked Questions

What is Aytu BioScience's stock symbol?

Aytu BioScience trades on the NASDAQ under the ticker symbol "AYTU."

When did Aytu BioScience's stock split? How did Aytu BioScience's stock split work?

Shares of Aytu BioScience reverse split on the morning of Tuesday, August 29th 2017. The 1-20 reverse split was announced on Friday, August 25th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 28th 2017. An investor that had 100 shares of Aytu BioScience stock prior to the reverse split would have 5 shares after the split.

How were Aytu BioScience's earnings last quarter?

Aytu BioScience (NASDAQ:AYTU) released its quarterly earnings results on Friday, February, 9th. The company reported ($0.89) earnings per share for the quarter, topping analysts' consensus estimates of ($1.78) by $0.89. The company earned $1.05 million during the quarter. Aytu BioScience had a negative net margin of 419.34% and a negative return on equity of 295.55%. View Aytu BioScience's Earnings History.

What price target have analysts set for AYTU?

1 analysts have issued 1-year price targets for Aytu BioScience's stock. Their forecasts range from $3.00 to $3.00. On average, they expect Aytu BioScience's share price to reach $3.00 in the next twelve months. View Analyst Ratings for Aytu BioScience.

Are investors shorting Aytu BioScience?

Aytu BioScience saw a decline in short interest during the month of April. As of April 13th, there was short interest totalling 265,333 shares, a decline of 49.0% from the March 30th total of 520,739 shares. Based on an average trading volume of 2,779,015 shares, the days-to-cover ratio is presently 0.1 days. Currently, 1.0% of the shares of the company are short sold.

Who are some of Aytu BioScience's key competitors?

Who are Aytu BioScience's key executives?

Aytu BioScience's management team includes the folowing people:
  • Mr. Joshua R. Disbrow, Chairman, CEO & Pres (Age 43)
  • Mr. Jarrett T. Disbrow Ph.D., Chief Operating Officer (Age 43)
  • Mr. David A. Green, CFO, Principal Accounting Officer, Sec. & Treasurer (Age 55)

Has Aytu BioScience been receiving favorable news coverage?

Media coverage about AYTU stock has trended somewhat positive recently, Accern reports. Accern rates the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Aytu BioScience earned a daily sentiment score of 0.13 on Accern's scale. They also gave media headlines about the company an impact score of 45.98 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Aytu BioScience?

Shares of AYTU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aytu BioScience's stock price today?

One share of AYTU stock can currently be purchased for approximately $0.56.

How big of a company is Aytu BioScience?

Aytu BioScience has a market capitalization of $3.19 million and generates $3.22 million in revenue each year. Aytu BioScience employs 63 workers across the globe.

How can I contact Aytu BioScience?

Aytu BioScience's mailing address is 373 INVERNESS PARKWAY SUITE 206, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-437-6580 or via email at [email protected]


MarketBeat Community Rating for Aytu BioScience (AYTU)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  68 (Vote Outperform)
Underperform Votes:  53 (Vote Underperform)
Total Votes:  121
MarketBeat's community ratings are surveys of what our community members think about Aytu BioScience and other stocks. Vote "Outperform" if you believe AYTU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AYTU will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Aytu BioScience (NASDAQ:AYTU) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Aytu BioScience in the last 12 months. Their average twelve-month price target is $3.00, suggesting that the stock has a possible upside of 435.71%. The high price target for AYTU is $3.00 and the low price target for AYTU is $3.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.002.502.50
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.00$3.00$3.00$3.00
Price Target Upside: 435.71% upside421.83% upside421.83% upside421.83% upside

Aytu BioScience (NASDAQ:AYTU) Consensus Price Target History

Price Target History for Aytu BioScience (NASDAQ:AYTU)

Aytu BioScience (NASDAQ:AYTU) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/6/2017HC WainwrightSet Price TargetBuy$3.00N/AView Rating Details
2/17/2017Taglich BrothersReiterated RatingSpeculative BuyN/AView Rating Details
9/26/2016Rodman & RenshawInitiated CoverageBuy$9.00N/AView Rating Details
(Data available from 4/25/2016 forward)

Earnings

Aytu BioScience (NASDAQ:AYTU) Earnings History and Estimates Chart

Earnings by Quarter for Aytu BioScience (NASDAQ:AYTU)

Aytu BioScience (NASDAQ AYTU) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/9/2018Q2 2018($1.78)($0.89)$1.05 millionViewN/AView Earnings Details
11/9/2017Q1 2018($7.60)($1.76)$1.08 millionViewN/AView Earnings Details
8/31/2017Q4 2017($12.00)($4.16)$0.84 millionViewN/AView Earnings Details
5/11/2017Q3 2017($0.28)($0.48)$1.08 million$0.89 millionViewN/AView Earnings Details
2/9/201712/31/2016($0.52)($0.55)$1.11 million$0.79 millionViewN/AView Earnings Details
11/7/2016Q1 2017($0.84)($1.17)$1.20 million$0.70 millionViewN/AView Earnings Details
9/1/2016Q4 2016($15.60)($45.40)$0.70 million$0.94 millionViewN/AView Earnings Details
5/11/2016Q3 2016($93.64)$0.67 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Aytu BioScience (NASDAQ:AYTU) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Aytu BioScience (NASDAQ AYTU) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 17.80%
Institutional Ownership Percentage: 7.35%
Insider Trading History for Aytu BioScience (NASDAQ:AYTU)

Aytu BioScience (NASDAQ AYTU) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/6/2018David A GreenCFOBuy66,600$0.45$29,970.00View SEC Filing  
3/6/2018Jarrett DisbrowCOOBuy226,105$0.45$101,747.25View SEC Filing  
1/20/2016Joshua R DisbrowCEOBuy153,846$0.65$99,999.90153,846View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Aytu BioScience (NASDAQ AYTU) News Headlines

Source:
DateHeadline
AYTU- Now That The Stock Dilution Has Passed, Its Time To Pay Attention To One Of The Safest And Most Effective APPROVED Testosterone Drugs On The Market, Natesto.AYTU- Now That The Stock Dilution Has Passed, It's Time To Pay Attention To One Of The Safest And Most Effective APPROVED Testosterone Drugs On The Market, Natesto.
seekingalpha.com - April 14 at 3:51 PM
Aytu BioScience to Present at The MicroCap Conference on April 10th in New York City at the Essex HouseAytu BioScience to Present at The MicroCap Conference on April 10th in New York City at the Essex House
finance.yahoo.com - April 3 at 10:08 AM
Aytu BioScience Announces Exercise of Underwriters Over-Allotment OptionAytu BioScience Announces Exercise of Underwriters' Over-Allotment Option
finance.yahoo.com - March 28 at 10:03 AM
Aytu BioScience Presents New Research Findings for Natesto(R) at the Endocrine Societys 100th Annual MeetingAytu BioScience Presents New Research Findings for Natesto(R) at the Endocrine Society's 100th Annual Meeting
finance.yahoo.com - March 20 at 9:58 AM
Has Aytu BioScience Inc (NASDAQ:AYTU) Improved Earnings Growth In Recent Times?Has Aytu BioScience Inc (NASDAQ:AYTU) Improved Earnings Growth In Recent Times?
finance.yahoo.com - March 9 at 10:40 AM
BRIEF-Bigger Capital Fund Reports 7.4 Pct Passive Stake In Aytu Bioscience As Of March 2BRIEF-Bigger Capital Fund Reports 7.4 Pct Passive Stake In Aytu Bioscience As Of March 2
www.reuters.com - March 8 at 4:58 PM
Form 4 AYTU BIOSCIENCE, INC For: Mar 06 Filed by: Disbrow JarrettForm 4 AYTU BIOSCIENCE, INC For: Mar 06 Filed by: Disbrow Jarrett
www.streetinsider.com - March 8 at 10:10 AM
Aytu Bioscience Inc (AYTU) CFO David A. Green Acquires 66,600 SharesAytu Bioscience Inc (AYTU) CFO David A. Green Acquires 66,600 Shares
www.americanbankingnews.com - March 7 at 7:46 PM
Insider Buying: Aytu Bioscience Inc (AYTU) COO Buys 226,105 Shares of StockInsider Buying: Aytu Bioscience Inc (AYTU) COO Buys 226,105 Shares of Stock
www.americanbankingnews.com - March 7 at 7:15 PM
Aytu BioScience Receives Market Registration for the MiOXSYS® System for Male Infertility in MexicoAytu BioScience Receives Market Registration for the MiOXSYS® System for Male Infertility in Mexico
finance.yahoo.com - March 7 at 9:55 AM
Aytu BioScience Announces Closing of $12,000,000 Public OfferingAytu BioScience Announces Closing of $12,000,000 Public Offering
finance.yahoo.com - March 6 at 4:35 PM
Aytu Bioscience (AYTU) Announces Quarterly  Earnings ResultsAytu Bioscience (AYTU) Announces Quarterly Earnings Results
www.americanbankingnews.com - February 9 at 11:02 AM
Aytu BioScience Provides Fiscal Second Quarter 2018 Business Update - Live Conference Call and Webcast Today at 4:30 pm ETAytu BioScience Provides Fiscal Second Quarter 2018 Business Update - Live Conference Call and Webcast Today at 4:30 pm ET
finance.yahoo.com - February 8 at 4:35 PM
Aytu BioScience to Report Fiscal Second Quarter 2018 Results and Business UpdateAytu BioScience to Report Fiscal Second Quarter 2018 Results and Business Update
finance.yahoo.com - February 1 at 9:02 AM
Aytu Bioscience (AYTU) Scheduled to Post Earnings on WednesdayAytu Bioscience (AYTU) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - January 31 at 2:10 AM
Is Aytu BioScience Inc’s (NASDAQ:AYTU) Liquidity As Good As Its Solvency?Is Aytu BioScience Inc’s (NASDAQ:AYTU) Liquidity As Good As Its Solvency?
finance.yahoo.com - January 2 at 10:29 AM
Aytu BioScience, Inc. to Present at the 10th Annual LD Micro Main EventAytu BioScience, Inc. to Present at the 10th Annual LD Micro Main Event
finance.yahoo.com - November 29 at 10:48 AM
Aytu BioScience Provides Update on the Continued Growth of Natesto® in the U.S.Aytu BioScience Provides Update on the Continued Growth of Natesto® in the U.S.
finance.yahoo.com - November 28 at 11:15 AM
Aytu BioScience, Inc. :AYTU-US: Earnings Analysis: Q1, 2018 By the Numbers : November 28, 2017Aytu BioScience, Inc. :AYTU-US: Earnings Analysis: Q1, 2018 By the Numbers : November 28, 2017
finance.yahoo.com - November 28 at 11:15 AM
BRIEF-Aytu Bioscience files for mixed shelf of upto $100 mlnBRIEF-Aytu Bioscience files for mixed shelf of upto $100 mln
www.reuters.com - November 22 at 10:00 PM
AYTU BIOSCIENCE, INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersAYTU BIOSCIENCE, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - November 16 at 8:55 PM
Q1 2017 Aytu BioScience Inc Earnings Release - Time Not SuppliedQ1 2017 Aytu BioScience Inc Earnings Release - Time Not Supplied
biz.yahoo.com - November 7 at 1:40 PM
AYTU BIOSCIENCE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial StatemenAYTU BIOSCIENCE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statemen
biz.yahoo.com - November 2 at 10:18 PM
Aytu BioScience Further Demonstrates Clinical Utility for MiOXSYS™ System as an Aid in the Diagnosis of Male InfertilityAytu BioScience Further Demonstrates Clinical Utility for MiOXSYS™ System as an Aid in the Diagnosis of Male Infertility
www.prnewswire.com - November 1 at 9:11 PM
Aytu BioScience to Present at Two Upcoming Investor ConferencesAytu BioScience to Present at Two Upcoming Investor Conferences
www.prnewswire.com - September 14 at 3:43 PM
Q4 2016 Aytu BioScience Inc Earnings Release - Time Not SuppliedQ4 2016 Aytu BioScience Inc Earnings Release - Time Not Supplied
biz.yahoo.com - September 1 at 12:09 PM
AYTU BIOSCIENCE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhiAYTU BIOSCIENCE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
biz.yahoo.com - September 1 at 12:09 PM
Acerus Pharmaceuticals (TRLPF) CEO Tom Rossi on Q2 2016 Results - Earnings Call TranscriptAcerus Pharmaceuticals' (TRLPF) CEO Tom Rossi on Q2 2016 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 4:48 PM
AYTU BIOSCIENCE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity SecuAYTU BIOSCIENCE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu
biz.yahoo.com - August 2 at 8:29 AM
Testosterone replacement treatment is opportunity for Colorado companyTestosterone replacement treatment is opportunity for Colorado company
www.bizjournals.com - July 8 at 8:52 PM

SEC Filings

Aytu BioScience (NASDAQ:AYTU) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Aytu BioScience (NASDAQ AYTU) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.